These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
889 related articles for article (PubMed ID: 32988361)
1. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
2. Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. Chauhan MK; Sharma PK Chem Phys Lipids; 2019 Nov; 224():104794. PubMed ID: 31361985 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured Lipid Carrier-Mediated Transdermal Delivery System of Glibenclamide for Gestational Diabetes: Pharmacokinetic and Pharmacodynamic Evaluation. Ashwini M; Sudheer P; Sogali BS Curr Drug Deliv; 2024; 21(10):1386-1407. PubMed ID: 38213159 [TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study. Kshirsagar SJ; Bhalekar MR; Mohapatra SK Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study. Sharma M; Sharma R; Jain DK; Saraf A Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197 [TBL] [Abstract][Full Text] [Related]
6. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
7. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Soni K; Rizwanullah M; Kohli K Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147 [TBL] [Abstract][Full Text] [Related]
8. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design. Sharma A; Singh AP; Harikumar SL Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777 [No Abstract] [Full Text] [Related]
9. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
11. Design, optimization and characterization of atorvastatin loaded chitosan-based polyelectrolyte complex nanoparticles based transdermal patch. Patil P; Vankani A; Sawant K Int J Biol Macromol; 2024 Aug; 274(Pt 1):133219. PubMed ID: 38897514 [TBL] [Abstract][Full Text] [Related]
12. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment. Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906 [TBL] [Abstract][Full Text] [Related]
13. Development of carvedilol-loaded lipid nanoparticles with compatible lipids and enhanced skin permeation in different skin models. Esteves NLS; Andrade LM; Krawczyk-Santos AP; Souza BDS; Marreto RN; Taveira SF J Microencapsul; 2021 Mar; 38(2):124-133. PubMed ID: 33305646 [TBL] [Abstract][Full Text] [Related]
14. Dry Gel Containing Optimized Felodipine-Loaded Transferosomes: a Promising Transdermal Delivery System to Enhance Drug Bioavailability. Kassem MA; Aboul-Einien MH; El Taweel MM AAPS PharmSciTech; 2018 Jul; 19(5):2155-2173. PubMed ID: 29714001 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers. Raval S; Jani P; Patil P; Thakkar P; Sawant K Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598 [No Abstract] [Full Text] [Related]
17. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats. Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496 [TBL] [Abstract][Full Text] [Related]
19. Nanotransethosomes for enhanced transdermal delivery of mangiferin against rheumatoid arthritis: formulation, characterization, invivo pharmacokinetic and pharmacodynamic evaluation. Adin SN; Gupta I; Rashid MA; Alhamhoom Y; Aqil M; Mujeeb M Drug Deliv; 2023 Dec; 30(1):2173338. PubMed ID: 36729134 [TBL] [Abstract][Full Text] [Related]
20. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system. Zhao X; Sun Y; Li Z Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]